Ryman Healthcare's market value is the price at which a share of Ryman Healthcare trades on a public exchange. It measures the collective expectations of Ryman Healthcare Limited investors about its performance. Ryman Healthcare is trading at 1.41 as of the 16th of February 2026. This is a No Change since the beginning of the trading day. The stock's lowest day price was 1.41. With this module, you can estimate the performance of a buy and hold strategy of Ryman Healthcare Limited and determine expected loss or profit from investing in Ryman Healthcare over a given investment horizon. Check out Ryman Healthcare Correlation, Ryman Healthcare Volatility and Ryman Healthcare Performance module to complement your research on Ryman Healthcare.
It's important to distinguish between Ryman Healthcare's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Ryman Healthcare should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Conversely, Ryman Healthcare's market price signifies the transaction level at which participants voluntarily complete trades.
Ryman Healthcare 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Ryman Healthcare's pink sheet what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Ryman Healthcare.
0.00
11/18/2025
No Change 0.00
0.0
In 3 months and 1 day
02/16/2026
0.00
If you would invest 0.00 in Ryman Healthcare on November 18, 2025 and sell it all today you would earn a total of 0.00 from holding Ryman Healthcare Limited or generate 0.0% return on investment in Ryman Healthcare over 90 days. Ryman Healthcare is related to or competes with Galapagos, Medicover, Medicover, Ansell, Jinxin Fertility, Shandong Weigao, and Medipal Holdings. Ryman Healthcare Limited develops, owns, and operates integrated retirement villages, rest homes, and hospitals for the ... More
Ryman Healthcare Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Ryman Healthcare's pink sheet current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Ryman Healthcare Limited upside and downside potential and time the market with a certain degree of confidence.
Today, many novice investors tend to focus exclusively on investment returns with little concern for Ryman Healthcare's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Ryman Healthcare's standard deviation. In reality, there are many statistical measures that can use Ryman Healthcare historical prices to predict the future Ryman Healthcare's volatility.
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Ryman Healthcare. Your research has to be compared to or analyzed against Ryman Healthcare's peers to derive any actionable benefits. When done correctly, Ryman Healthcare's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Ryman Healthcare.
Ryman Healthcare February 16, 2026 Technical Indicators
Ryman Healthcare maintains Sharpe Ratio (i.e., Efficiency) of -0.13, which implies the firm had a -0.13 % return per unit of risk over the last 3 months. Ryman Healthcare exposes sixteen different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check Ryman Healthcare's Coefficient Of Variation of (812.40), variance of 5.72, and Risk Adjusted Performance of (0.09) to confirm the risk estimate we provide. The company holds a Beta of -0.45, which implies possible diversification benefits within a given portfolio. As returns on the market increase, returns on owning Ryman Healthcare are expected to decrease at a much lower rate. During the bear market, Ryman Healthcare is likely to outperform the market. At this point, Ryman Healthcare has a negative expected return of -0.31%. Please make sure to check Ryman Healthcare's information ratio, skewness, as well as the relationship between the Skewness and day median price , to decide if Ryman Healthcare performance from the past will be repeated at some point in the near future.
Auto-correlation
Huge
Perfect predictability
Ryman Healthcare Limited has perfect predictability. Overlapping area represents the amount of predictability between Ryman Healthcare time series from 18th of November 2025 to 2nd of January 2026 and 2nd of January 2026 to 16th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Ryman Healthcare price movement. The serial correlation of 9.223372036854776E16 indicates that 9.223372036854776E16% of current Ryman Healthcare price fluctuation can be explain by its past prices.
Other Information on Investing in Ryman Pink Sheet
Ryman Healthcare financial ratios help investors to determine whether Ryman Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Ryman with respect to the benefits of owning Ryman Healthcare security.